VINC
Vincerx Pharma, Inc. Common Stock
VINC
VINC
Delisted
VINC was delisted on the 22nd of April, 2025.
14 hedge funds and large institutions have $117K invested in Vincerx Pharma, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
-8
Holders Change %
-36.36%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
6
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Citadel Advisors
Miami,
Florida
|
+$22.6K |
2 |
TSS
Two Sigma Securities
New York
|
+$5.85K |
3 |
Millennium Management
New York
|
+$5.72K |
4 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.82K |
5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.59K |